Hip FracturesTibial FracturesAnkle FracturesHumeral Fracture, ProximalDistal Radius Fracture
Investigational drug(s) / intervention(s)
All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.
All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.: All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.
Study summary
Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups).
Patients will be followed up according to the standard (routine) for up to 1 year after the treatment.
Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age 18 years and older
* Diagnosis of one of, isolated injury
* Hip fracture
* Tibial shaft fracture (with and without associated fibular fracture)
* Ankle/pilon fracture
* Proximal humerus fracture
* Distal radius fracture
* English, German, or Spanish speaking
* Informed consent obtained, i.e.:
* Ability to understand the content of the patient information/ICF
* Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
* Signed and dated EC/IRB approved written informed consent
Exclusion Criteria:
* More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
* Patients with multiple fractures
* Pathological fractures due to cancer
* Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
* Pregnancy or women planning to conceive within the study period
* Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
* Prisoners
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
* Patients unable to likely achieve anticipated Follow-up (FU)
Primary outcome measure(s)
Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis — from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical) * Radiographic measurements
o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\])
* Patient related outcomes
* Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference
* Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms)
* Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms)
* Loading/Activity pattern analysis:
* Number of steps with weight-bearing \>80% body-weight (weight in kg)
* pressure distribution \[N/cm2\]
* center of pressure \[mm\]
* ground reaction forces \[N\]
* temporal and spatial parameters (time spent during gait \[min\], stance time \[s\], swing time \[s\], double support time \[s\], cadence \[r/min\], cycle time \[s\])
Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM — from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical) PROs that measure physical limitations:
* PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities)
* PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function)
* Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability)
* HOOS-12
* KOOS-12
* Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale)
* PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)
Trial sites (15)
Facility
City
Region
Status
Cedars-Sinai Department of Orthopaedics
Los Angeles
California
University of Miami, Jackson Memorial Hospital Ryder Trauma Center
Miami
Florida
Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
Boston
Massachusetts
The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin
Austin
Texas
Univ.-Klinik für Orthopädie und Traumatologie
Innsbruck
Austria
Fundación Santa Fe de Bogotá
Bogotá
Colombia
Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin
Berlin
Germany
University Hospital Freiburg
Freiburg im Breisgau
Germany
Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery
Homburg
Germany
Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau
Murnau am Staffelsee
Germany
Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen
Tübingen
Germany
University Medical Center Groningen
Groningen
Netherlands
Isala Clinics
Zwolle
Netherlands
Barts Health NHS Trust
London
United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford
United Kingdom
More AO Innovation Translation Center trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.